We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Offers Guidance on Managing Trails During the COVID-19 Outbreak
EMA Offers Guidance on Managing Trails During the COVID-19 Outbreak
Sponsors in the EU should conduct risk assessments of all trial procedures in the face of the COVID-19 outbreak, according to a guidance issued by the European Medicines Agency (EMA) on Friday that also suggests they should hold off on initiating trials or adding participants to current trials.